This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: University of Southampton, Imperial Innovations Limited. Active years: 2007-2015.
Location History:
- Hampshire, GB (2007)
- Romsey, GB (2009 - 2015)
Company Filing History:
Years Active: 2007-2015
Title: The Innovations of Stephen Holgate
Introduction
Stephen Holgate is a notable inventor based in Romsey, GB. He has made significant contributions to the field of respiratory disease treatment, holding a total of 4 patents. His work focuses on innovative therapies aimed at combating viral infections that exacerbate respiratory conditions.
Latest Patents
Among his latest patents is an anti-virus therapy for respiratory diseases. This invention provides the use of IFN-β, an agent that increases the expression of IFN-β, or a polynucleotide capable of expressing IFN-β. The patent outlines the manufacture of a medicament for treating rhinovirus-induced exacerbation of respiratory diseases, such as asthma and chronic obstructive pulmonary disease. The treatment is designed for airway delivery, utilizing methods like aerosol nebulization. Additionally, IFN-λ is also provided for the same therapeutic purpose.
Career Highlights
Stephen Holgate has had a distinguished career, working with reputable institutions such as the University of Southampton and Imperial Innovations Limited. His research and innovations have significantly impacted the medical community, particularly in the treatment of respiratory diseases.
Collaborations
Some of his notable coworkers include Donna Elizabeth Davies and Peter Alexander Blanch Wark. Their collaborative efforts have contributed to the advancement of research in respiratory therapies.
Conclusion
Stephen Holgate's innovative work in the field of respiratory disease treatment showcases his dedication to improving patient outcomes. His patents reflect a commitment to advancing medical science and providing effective solutions for respiratory conditions.